Frontlight ResearchEarly access
Trial site
Lexington Health
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Chronic lymphocytic leukaemia2 trials
- Kidney cancer2 trials
- Metastatic breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- and 4 more
- Phase
- Phase 36 trials
- Status
- Active, not recruiting5 trials
- Recruiting3 trials
- Lead sponsor
- National Cancer Institute (NCI)6 trials
- Alliance for Clinical Trials in Oncology1 trial
- SWOG Cancer Research Network1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026